HomeCompareIPA vs PM

IPA vs PM: Dividend Comparison 2026

IPA yields 123.46% · PM yields 3.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPA wins by $9.68M in total portfolio value
10 years
IPA
IPA
● Live price
123.46%
Share price
$1.62
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.73M
Annual income
$3,751,721.48
Full IPA calculator →
PM
Philip Morris International
● Live price
3.49%
Share price
$164.83
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,502.61
Full PM calculator →

Portfolio growth — IPA vs PM

📍 IPA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPAPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPA + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPA pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPA
Annual income on $10K today (after 15% tax)
$10,493.83/yr
After 10yr DRIP, annual income (after tax)
$3,188,963.26/yr
PM
Annual income on $10K today (after 15% tax)
$297.03/yr
After 10yr DRIP, annual income (after tax)
$2,127.22/yr
At 15% tax rate, IPA beats the other by $3,186,836.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPA + PM for your $10,000?

IPA: 50%PM: 50%
100% PM50/50100% IPA
Portfolio after 10yr
$4.89M
Annual income
$1,877,112.05/yr
Blended yield
38.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

IPA
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-1.1
Piotroski
4/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.9% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPA buys
0
PM buys
0
No recent congressional trades found for IPA or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPAPM
Forward yield123.46%3.49%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$9.73M$49.6K
Annual income after 10y$3,751,721.48$2,502.61
Total dividends collected$8.87M$11.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: IPA vs PM ($10,000, DRIP)

YearIPA PortfolioIPA Income/yrPM PortfolioPM Income/yrGap
1← crossover$23,046$12,345.68$11,650$409.56+$11.4KIPA
2$51,249$26,590.15$13,592$497.49+$37.7KIPA
3$110,099$55,262.82$15,882$605.21+$94.2KIPA
4$228,762$110,955.31$18,589$737.41+$210.2KIPA
5$460,233$215,458.11$21,794$899.94+$438.4KIPA
6$897,560$405,110.78$25,597$1,100.16+$872.0KIPA
7$1,698,762$738,373.02$30,118$1,347.30+$1.67MIPA
8$3,123,730$1,306,054.02$35,505$1,652.97+$3.09MIPA
9$5,586,883$2,244,492.70$41,940$2,031.88+$5.54MIPA
10$9,729,687$3,751,721.48$49,643$2,502.61+$9.68MIPA

IPA vs PM: Complete Analysis 2026

IPAStock

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Full IPA Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this IPA vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPA vs SCHDIPA vs JEPIIPA vs OIPA vs KOIPA vs MAINIPA vs MOIPA vs BTIIPA vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.